Optimizing Vancomycin Monitoring in Pediatric Patients
Conclusions:
In conclusion, targeting vancomycin trough levels above 15 µg/mL in pediatrics would overshoot the target AUC0–24h above 400 and expose them to unnecessary adverse events.
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Antimicrobial Reports Source Type: research
More News: Infectious Diseases | Intensive Care | Middle East Health | Pediatrics | Saudi Arabia Health | Study